SEREXISTM 180 - The Serum Alternative
Ready for the Next Step in Cell Culture?
For decades, fetal bovine serum (FBS) has been the gold standard in cell culture. It delivers robustness and familiarity — but also natural variability and limited control. SEREXISTM 180 represents the next generation: a true serum alternative designed to maintain FBS-like performance while eliminating serum uncertainty.
Developed from decades of expertise in high-quality serum manufacturing and advanced chemically defined media formulation, SEREXISTM 180 starts where conventional serum ends.
Why SEREXISTM 180?
Delivers the robustness of FBS while ensuring superior reproducibility through a defined, homogeneous formulation.
Direct replacement for FBS at standard concentrations, compatible with a wide range of cell lines and existing workflows.
Defined and gamma-irradiated components provide enhanced viral safety and reliable cell culture conditions.
Controlled Cell Culture Begins
Where Serum Uncertainty Ends
SEREXISTM 180 is a defined and homogeneous serum replacement that delivers FBS-like performance across a wide range of cell types. Designed to closely mimic the functional properties of fetal bovine serum (FBS), it enables efficient cell growth and performance without the variability and safety limitations associated with conventional serum.
Thanks to its controlled, defined composition, SEREXISTM 180 ensures a high level of reproducibility, consistency, and process control in cell culture workflows. The formulation is broadly applicable across multiple cell lines, making it a versatile solution for making it a versatile solution for most cell culture applications.
SEREXISTM180 is easy to switch and can be used as a direct replacement for FBS at standard serum concentrations, allowing seamless integration into established protocols without the need for workflow changes or extensive re-optimization.
By combining FBS-like efficacy, defined composition, and built-in safety, SEREXISTM 180 offers a reliable and future-ready alternative to traditional serum for robust and reproducible cell culture applications.
Fig.1: SEREXISTM 180 Shows Robust Growth Promotion on Multiple Cell Types Without Changing Workflows.
